Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on IDT Australia.
RELATED STOCKHEAD STORIES
Health & Biotech
ASX Health Stocks: HITIQ secures US patent; BlinkLab joins forces in Europe to transform ADHD diagnosis
Health & Biotech
Weed Week: MDMA for PTSD hits roadblock with FDA; and recent ASX cannabis stock winners
News
Rise and Shine: Everything you need to know before the ASX opens
News
ASX Small Caps and IPO Weekly Wrap: The ASX walked backwards again this week as investors battle tough conditions
News
Closing Bell: ASX up again as iron ore miners rally; Qantas to pay $120m for ‘ghost flights’ fiasco
Health & Biotech
ASX Health Stocks: Lumos passes milestone with Nasdaq-listed Hologic to revolutionise birth diagnosis
Health & Biotech
ASX Health Winners April: Mesoblast leads; and why the Health sector is just built different
Health & Biotech
Weed Week: A VAST majority of Americans now want marijuana to be legal
News
Rise and Shine: Everything you need to know before the ASX opens
News
Closing Bell: ASX crushed with all 11 sectors deep in the red, but there’s some good news from China
Health & Biotech
ASX Health Stocks: Island Pharma releases data on dengue fever drug, IDT signs $3m+ deal with Sanofi
Health & Biotech
Weed Week: Cannabis stocks down almost 20pc in 2023, but here’s why they could rebound by Q2 2024
Health & Biotech
Weed Week: Cannabis boom a ‘matter of when, not if’; and NSW to allow residents to grow pot
Health & Biotech
ASX Health Winners: Biotechs up 10pc in November, and Janus Henderson’s prediction for 2024
Health & Biotech
Check Up: Imugene’s oncolytic virus VAXINIA granted FDA’s Fast Track, but how effective is this novel therapy?
Health & Biotech
Check Up: Biden-Xi meeting could finally end opioids crisis in the US; and recent ASX biotech winners
Health & Biotech
